Armata Pharmaceuticals (ARMP) Return on Assets (2014 - 2026)

Armata Pharmaceuticals (ARMP) has 13 years of Return on Assets data on file, last reported at 0.02% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (changed 0.0% YoY), and the FY2025 full-year result was 0.02%, changed 0.0% from the prior year.
• Return on Assets declined to 0.02% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2022 to a low of 0.02% in Q1 2026.
• A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
• Peak annual rise in Return on Assets reached 1 bps in 2025, while the deepest fall reached 2 bps in 2025.
• Tracing ARMP's Return on Assets over 5 years: stood at 0.0% in 2022, then sank by 46 bps to 0.01% in 2023, then plunged by 219 bps to 0.02% in 2024, then jumped by 37 bps to 0.01% in 2025, then plunged by 72 bps to 0.02% in 2026.
• Business Quant data shows ARMP's Return on Assets at 0.02% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.